Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

3 Mid-Sized Stocks to Consider This Season

As the festive season approaches, mid-cap stocks often present overlooked opportunities for investors seeking growth and stability in their portfolios. This asset class combines the agility of smaller firms with the reliability of established players, making them an ...
Lyndsay Malchuk | 5 days ago |

Brianne Gardner's 2025 stock picks

As you will see in the full video above, Brianne Gardner , senior wealth manager at Velocity Investments, Raymond James Canada reviews her past picks from September to see if they are on the money and she gives three new diversified picks for 2025 in healthcare, ener...
Coreena Robertson | 7 days ago |

A potential breakthrough in spinal cord and optic nerve injury treatment

Click Here to Download the Full Report This is third-party provided content issued on behalf of NurExone Biologic Inc., please see full disclaimer here .
Research | 7 days ago |

dynaCERT: Growth Rocket 2025 – Why It’s in the Spotlight

As 2024 draws to a close, it is worth considering new investments for the future. A successful investment in the technology sector requires a sound strategy, thorough research, and an understanding of the ins and outs of the industry. We have summarized key points for in...
Mario Hose | 10 days ago |

In conversation with: Pierre Gratton: How can we built more mines faster in Canada?

The Mining Association of Canada’s President and CEO Pierre Gratton discusses his Vancouver Board of Trade presentation addressing the question, “How can we build more mines faster? He covers several key issues including, the need for critical miner...
Coreena Robertson | December 12, 2024 |

Buzz on the Bullboards: Feeling holiday blues, or celebrating blue chip stocks?

Are you anticipating a calm market as the holidays approach? Think again. Astute investors and brokers recognize that this is their moment to excel. With the global economy constantly shifting, staying active is the smart move. Over the past week, some shareholde...
Jonathon Brown | December 12, 2024 |

BoC’s Double Rate Cut: Is it a benefit for Canadians

The Bank of Canada (BoC) has implemented a 50-basis-point interest rate cut. This is in responds to a weakening labor market and a 5-year bond yield drop to 2.8%. With unemployment at 6.8%—its highest since 2017 (excluding pandemic years)—the move aims to stimulate the ec...
Lyndsay Malchuk | December 11, 2024 |

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research | December 11, 2024 |

Lode Gold: A compelling investment opportunity for gold enthusiasts

Lode Gold (TSXV:LOD) has had a year of growth achieving one milestone after another. Despite facing a challenging market, the company has successfully raised $6M since March 2024. Now, investors have the chance to capitalize on a unique opportunity by investing in Lode ...
Research | December 4, 2024 |

Drilling underway at a large copper-moly porphyry target in Peru

Western Metallica Resources Corp. (TSXV:WMS ), a mineral exploration company headquartered in Toronto, Ontario, with five mineral assets across Peru and Spain has drilling underway in Peru. The Market Online recently sat down with CEO, Gregory Duras. The following i...
Lyndsay Malchuk | December 2, 2024 |
1 2 3 4 5 6 7 8 9 10 ...